The new-look robotics system can help specialists perform remote mechanical thrombectomies from bedside or as far as thousands of miles away. 

Researchers say their new analysis, based on five years of U.S. data, highlights just how important it is to keep post-TAVR PPMI rates to a minimum. 

Ken Rosenfield, MD, of Massachusetts General Hospital, and William Gray, MD, of Lankenau Heart Institute, detailed the long-term impact of a key policy shift. 

Interventional cardiologists have been anticipating this news for quite some time. The device, the first of its kind, provides an alternative treatment option to repeat PCI or cardiac surgery for patients with coronary ISR.

The procedure, performed on Feb. 14, was part of an early feasibility trial developed with help from the FDA.

The news represents yet another big regulatory approval for PFA technology in 2024. Could FDA approval be next for Biosense Webster?

Nearly 80% of Black and Hispanic adults said they never discussed PAD with a doctor, which vascular experts say is a major problem.

The self-expandable device was designed to treat “no-option” chest pain patients who see no long-term benefits from other interventions.